Newsroom

Coloplast, a global medical device company and leader in intimate healthcare needs, has been awarded an AscenDrive agreement with Premier, Inc. AscenDrive is a national program designed to standardize the care delivery process and help drive the highest-level commitment and savings for members. Effective July 1, 2022, Coloplast is one of two suppliers awarded the AscenDrive contract for ostomy products.

Premier is a leading healthcare improvement company uniting an alliance of approximately 4,400 U.S. hospitals and health systems and more than 225,000 other providers and organizations. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost.

“This agreement is an important milestone in our journey to establish full access in the U.S. for Coloplast, the world's No. 1 Ostomy brand. We are honored to have received this contract and look forward to working with Premier to provide products and services that create value for the AscenDrive membership,” said Manu Varma, Senior Vice President of Chronic Care North America.

About Coloplast ostomy products
Coloplast is dedicated to advancing the ostomy care industry. By continuously gathering feedback from clinicians and patients, Coloplast is able to innovate and solve daily problems for ostomy care. 

Coloplast also offers additional support through the Coloplast® Care program, which provides product and lifestyle advice, inspiration, and education resources for people living with an ostomy. 

About Coloplast
Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to end-users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions. Visit Coloplast.us for more information. 

Coloplast's SenSura® Mio ostomy system has been approved in the US for extended wear use, which represents the majority of the US ostomy barrier market².

"Although the brand was initially launched into the standard wear category, new data shows SenSura Mio is a great option for those seeking an extended wear product," said Manu Varma, President and SVP of Chronic Care North America.

A recent survey of nearly 2,400 patients demonstrated that SenSura Mio reduces leakage while matching or outperforming the wear time of other extended wear products¹. When combined with its full-circle filter, discreet neutral-gray textile, wide outlet, and unique BodyFit Technology, SenSura Mio is now an option for ostomates seeking an extended wear solution that also addresses their concerns around leakage.

Key clinical studies have found:

• 91% of ostomates worry to some degree about leakage³
• 76% of ostomates experienced leakage on some level ranging from a very high degree to a low degree⁴

A secure fit to the body is important to reducing leakage, and SenSura Mio was designed to fit individual bodies. BodyFit Technology is an elastic adhesive technology that is unique to SenSura® Mio barriers, which adheres securely to the body for protection and provides a flexible fit during movement.

"Patients¹, clinicians⁵, and lab-based data⁶ confirmed what we have suspected: SenSura Mio performs very well in the extended wear market," added Varma. "We believe in the strength of our innovative products and are proud more patients in the US now have access to our reliable extended wear solution offered with SenSura Mio."

Coloplast is a medical device company that develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to its users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions.

1 Ostomy pouch user survey, 2021, n= 2,359. Dataset collected by Coloplast but includes all brands. Data on file.

2 2017 Medicare data, https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/Downloads/DMEPOS_National_2017.zip

3 Ostomy Leak Impact tool, https://hqlo.biomedcentral.com/articles/10.1186/s12955-018-1054-0

4 The Ostomy Life Study: The everyday challenges faced by people living with a stoma in a snapshot, n=4138, June 2015

5 Product evaluation of SenSura Mio Convex, 2016, n=98 clinicians.

6 Data from bench testing performed by Coloplast. Data on file.

Coloplast announced today that between now and December 2022 it is awarding $150,000 in grants to nonprofits in the Twin Cities. The goal is to help address inequities and bring about positive change in the lives of underrepresented members of the Twin Cities community, specifically people of color (BIPOC). Through this new program $50,000 will go toward a strategic partnership with one local nonprofit. Additional grant dollars will also be available via Coloplast's new community grant program, which will award grants to Twin Cities-based charitable organizations that offer programs focused on developing science, technology, engineering, and math (STEM) skills in youth and adult groups.

"Coloplast is committed to being an active and meaningful participant in our local community," said Manu Varma, President at Coloplast. "We recognize there is a critical need in the Twin Cities, especially among underserved and underrepresented members of our BIPOC communities. With our North American headquarters located in North Minneapolis, we want to help create lasting and impactful ways to bring about positive change. We will do that by partnering with and supporting organizations that help develop the next generation of healthcare industry professionals in the Twin Cities."

The new community engagement program includes two components: a strategic, year-long partnership with one local Twin Cities nonprofit and a new community grant program. Through the new strategic community partnership program, Coloplast has selected The Boys & Girls Club of the Twin Cities, awarding the organization $50,000, which will fund its Academic Success programming at the Jerry Gamble Club, located in North Minneapolis. In addition, Coloplast employees will volunteer at the Club and youth at the Club will have access to Coloplast via various opportunities throughout the year. This strategic community partnership will run through December 2022.

"The Boys & Girls Clubs of the Twin Cities are incredibly honored to partner with Coloplast in building and enhancing the STEM skills of young people in North Minneapolis," said Terryl Brumm, President & CEO of Boys & Girls Clubs of the Twin Cities. "Strong STEM programming develops the critical thinking, problem solving, decision-making, and technology literacy skills necessary for our youth to succeed in the 21st century."

The intent of the new community grant program is to help prepare and develop the next generation of healthcare industry professionals in underserved communities by awarding grants to organizations that offer educational programs focused on developing STEM or medical industry-related skills. Funds will be prioritized toward programming that benefits underserved communities and North Minneapolis residents. Grants will be awarded annually, starting in early 2022 and the application period opens September 1, 2021.

"Coloplast's vision is to set the standard of listening and responding," added Varma. "Over the past year, we have taken great efforts to understand what the needs are in our local community. With this new program, we are helping all members of our community have more equal opportunities to succeed."

Coloplast is a medical device company that develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to its users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions.

About Boys & Girls Clubs of the Twin Cities – GREAT FUTURES START HERE. - Through our long and rich history, experience, and expertise, Boys & Girls Clubs of the Twin Cities is leading a transformative change in the opportunity equation for Twin Cities youth through our programs at 10 Club locations and one environmental learning center. We believe that every young person deserves the chance to realize his or her full potential and achieve a great future. Our K-12 youth development continuum is an inclusive model that helps prepare all young people succeed in school, develop leadership skills, maintain healthy lifestyles, and build career aspirations. As Boys & Girls Clubs of the Twin Cities, we take a stand for the future of our youth against racism, discrimination, and prejudice in all its forms. We are committed to safety, health, dignity, and equitable opportunity for all youth.

On June 20, it was announced that Coloplast US is included as a 2021 National Standard Top Workplace in the Star Tribune’s Top Workplaces in Minnesota. This is the second year the company has been included in the Top Workplaces program, receiving recognition for its commitment to company culture, specifically around trust in company direction, well-informed employees, and strong company values.

The Star Tribune recognizes the most progressive companies in Minnesota based on employee opinions measuring engagement, organizational health, and satisfaction. The analysis included responses from more than 77,000 employees at nearly 3,000 Minnesota public, private and non-profit organizations. Rankings were composite scores calculated based solely on employee responses.

“This recognition underscores Coloplast’s position as a top employer for those looking to advance their careers at a fast-growing, closely-knit company that prioritizes trust, collaboration, and open communication,” said Manu Varma, president and SVP of Chronic Care North America.

Star Tribune Publisher Michael J. Klingensmith said, “The companies in the Star Tribune Top Workplaces deserve high praise for creating the very best work environments in the state of Minnesota. My congratulations to each of these exceptional companies.”

Coloplast is a medical device company that develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to its users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions.

Coloplast is growing and hiring for many positions. To see current job openings and learn how to join the Coloplast team, visit the company’s Careers page.